CCL2 and neoplasm: Furthermore, in the HNSCCs microenvironment, a high amount of MCP-1 induced the recruitment of activated regulatory T lymphocytes, which suppress tumor-associated antigen effector T-cell immune responses and inhibit the effectiveness of RT in HNSCCs patients [37,38].